The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

NCT03038035 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: MLC901
DRUG: Placebo

Sponsor

National University Hospital, Singapore